method
retrospect
studi
conduct
cap
patient
admit
tertiari
referr
centr
avail
enhanc
ct
scan
imag
patient
alloc
np
nonnp
group
compar
respect
variou
clinic
variabl
result
patient
includ
present
studi
necrot
chang
observ
patient
patient
np
experienc
symptom
pneumonia
higher
blood
level
inflammatori
marker
often
requir
pleural
drainag
compar
patient
nonnp
although
use
mechan
ventil
vasopressor
infus
mortal
inhospit
mortal
clinic
deterior
differ
np
nonnp
group
median
length
hospit
stay
lo
significantli
longer
np
group
multivari
analysi
use
cox
proport
hazard
model
show
necrot
chang
independ
predict
lo
patient
cap
conclus
np
affect
approxim
onetenth
hospit
cap
patient
may
associ
sever
clinic
manifest
may
increas
need
pleural
drainag
np
found
independ
predictor
lo
mortal
cap
patient
necrot
pneumonia
np
character
pulmonari
inflamm
consolid
peripher
necrosi
format
multipl
cavitari
lesion
toxin
invas
pathogen
vascul
venou
thrombosi
suggest
involv
perturb
bronchial
pulmonari
vascular
suppli
preced
necrot
chang
lung
parenchyma
tissu
necrosi
disrupt
deliveri
antibiot
infect
lung
area
caus
persist
infect
progress
destruct
pulmonari
parenchyma
result
bronchopleur
fistula
empyema
septic
shock
pulmonari
gangren
investig
clinic
featur
communityacquir
necrot
pneumonia
necrot
chang
note
approxim
patient
communityacquir
pneumonia
cap
character
sever
clinic
manifest
increas
need
pleural
drainag
necrot
chang
predictor
length
hospit
stay
lo
mortal
patient
cap
regard
marker
final
stage
progress
lung
destruct
furthermor
np
consid
rare
sever
complic
bacteri
communityacquir
pneumonia
cap
chest
radiograph
np
manifest
rapid
progress
airspac
diseas
develop
caviti
howev
plain
chest
radiographi
inadequ
diagnost
tool
underestim
parenchym
destruct
comput
tomographi
ct
scan
contrast
enhanc
provid
sensit
diagnost
modal
standard
procedur
diagnosi
np
ct
scan
np
character
pneumon
consolid
multipl
area
necrosi
lung
parenchyma
describ
detect
np
imag
studi
might
rais
concern
poor
prognosi
subsequ
treatment
failur
howev
studi
use
ct
scan
diagnosi
np
larg
number
patient
especi
adult
scarc
addit
data
regard
incid
np
differ
np
nonnp
limit
aim
present
studi
determin
incid
np
among
cap
patient
compar
clinic
variabl
patient
without
np
therebi
elucid
prognost
role
necrot
chang
patient
consecut
cap
patient
admit
treat
respiratori
depart
kyungpook
nation
univers
hospit
knuh
tertiari
referr
centr
daegu
korea
januari
decemb
identifi
use
cap
patient
registri
patient
enrol
admiss
baselin
characterist
record
although
patient
underw
laboratori
test
pneumonia
diagnos
use
follow
criteria
new
radiograph
infiltr
ii
one
compat
symptom
sign
cough
sputum
dyspnoea
fever
andor
pleurit
chest
pain
exclus
criteria
cap
appli
follow
hospitalacquir
pneumonia
healthcareassoci
pneumonia
ii
presenc
activ
thorac
malign
iii
immunosuppress
steroid
use
mgday
prednison
day
two
chest
radiologist
km
jkl
independ
review
ct
scan
imag
patient
presenc
necrot
chang
np
defin
consolid
multipl
area
nonenhanc
without
rim
enhanc
contrastenhanc
ct
scan
one
pulmonari
segment
lobe
patient
without
avail
enhanc
ct
scan
present
exclud
patient
alloc
np
nonnp
group
base
presenc
absenc
necrot
chang
clinic
paramet
compar
two
group
present
studi
approv
institut
review
board
knuh
waiv
requir
written
inform
consent
patient
owe
retrospect
natur
studi
two
chest
physician
hs
sic
analys
data
symptom
vital
sign
comorbid
condit
pneumonia
sever
indic
psi
score
sixpoint
score
one
point
confus
urea
mmoll
respiratori
rate
low
systol
mm
hg
diastol
mm
hg
blood
pressur
age
year
review
baselin
data
initi
record
resid
physician
confirm
attend
chest
physician
charlson
comorbid
indic
cci
calcul
retrospect
inform
therapeut
intervent
includ
mechan
ventil
corticosteroid
use
vasopressor
infus
pleural
drainag
percutan
cathet
chest
tube
collect
length
hospit
stay
lo
admiss
intens
care
unit
icu
mortal
inhospit
mortal
clinic
deterior
select
outcom
variabl
clinic
deterior
defin
initi
mechan
ventil
vasopressor
infus
icu
admiss
inhospit
mortal
laboratori
data
includ
complet
blood
cell
count
erythrocyt
sediment
rate
esr
liver
function
test
creactiv
protein
crp
procalcitonin
ntermin
prohormon
brain
natriuret
peptid
blood
urea
nitrogen
creatinin
arteri
blood
ga
analysi
data
review
caus
pathogen
consid
one
follow
criteria
met
isol
microorgan
blood
pleural
fluid
posit
urinari
antigen
test
streptococcu
pneumonia
legionella
pneumophila
serogroup
tabl
supplementari
inform
identif
bacteria
sputum
sampl
neutrophil
squamou
epitheli
cell
per
lower
power
field
collect
within
h
admiss
plu
compat
gramstain
find
posit
mycoplasma
pneumonia
chlamydia
pneumonia
determin
posit
igm
result
fourfold
increas
igg
level
initi
convalesc
sampl
tabl
supplementari
inform
posit
respiratori
virus
throat
nasopharyng
swab
multiplex
pcr
tabl
supplementari
inform
identif
influenza
b
antigen
influenza
throat
swab
tabl
supplementari
inform
potenti
drugresist
pathogen
detect
includ
methicillinresist
staphylococcu
aureu
mrsa
pseudomona
aeruginosa
acinetobact
baumannii
stenotrophomona
maltophilia
extendedspectrum
enterobacteriacea
statist
analysi
perform
use
ibm
spss
statist
window
version
ibm
corp
armonk
ny
usa
pvalu
consid
statist
signific
data
express
mean
ae
sd
median
interquartil
rang
iqr
nonnorm
distribut
continu
variabl
number
percentag
categor
variabl
continu
variabl
compar
use
student
ttest
mannwhitney
utest
nonnorm
distribut
wherea
categor
variabl
compar
use
chisquar
test
fisher
exact
test
lo
analys
use
kaplanmei
method
patient
die
censor
analysi
independ
prognost
factor
lo
identifi
use
stepwis
forward
cox
regress
model
initi
cap
patient
identifi
patient
without
avail
enhanc
ct
scan
patient
ct
scan
imag
nonenhanc
ct
scan
imag
exclud
consequ
patient
includ
studi
alloc
np
group
nonnp
group
patient
np
demograph
character
higher
percentag
male
eversmok
heavi
drinker
compar
nonnp
group
tabl
comorbid
condit
tabl
supplementari
inform
gastrectomi
diabet
chronic
liver
diseasewer
common
np
group
howev
cci
differ
significantli
two
group
patient
np
group
experienc
significantli
symptom
includ
dyspnoea
fever
haemoptysi
chest
pain
patient
nonnp
group
score
high
rate
similar
two
group
psi
class
significantli
higher
vs
p
high
psi
class
tend
common
vs
p
np
group
pleural
drainag
perform
significantli
often
np
group
vs
p
intergroup
differ
note
use
mechan
ventil
vasopressor
infus
icu
admiss
mortal
inhospit
mortal
clinic
deterior
contrast
median
lo
significantli
longer
np
group
day
day
vs
day
day
p
inflammatori
marker
includ
white
blood
cell
count
esr
crp
significantli
higher
level
serum
albumin
sodium
significantli
lower
np
group
tabl
np
group
pathogen
identifi
patient
nonnp
group
pathogen
identifi
patient
tabl
common
pathogen
np
group
klebsiella
pneumonia
n
follow
pneumonia
n
aureu
n
klebsiella
pneumonia
vs
p
aureu
vs
p
streptococcu
milleri
group
vs
p
significantli
common
np
group
wherea
pneumonia
vs
p
significantli
less
common
hand
frequenc
potenti
drugresist
pathogen
similar
two
group
np
group
ampicillinsulbactam
without
macrolid
fluoroquinolon
commonli
use
antibiot
regimen
follow
cefotaxim
ceftriaxon
plu
clindamycin
tabl
regimen
administ
significantli
often
np
group
vs
p
vs
p
respect
cefotaxim
ceftriaxon
without
macrolid
fluoroquinolon
less
frequent
administ
vs
p
np
group
mention
lo
outcom
variabl
differ
significantli
two
group
kaplanmei
curv
construct
np
nonnp
group
fig
patient
np
significantli
like
stay
longer
hospit
compar
without
np
logrank
p
breslow
p
thu
tri
identifi
factor
associ
lo
set
two
model
base
two
clinic
predict
score
psi
data
present
mean
ae
sd
median
interquartil
rang
n
alp
alkalin
phosphatas
alt
alanin
transaminas
ast
aspart
aminotransferas
bun
blood
urea
nitrogen
esr
erythrocyt
sediment
rate
fio
inspir
oxygen
fraction
ldh
lactat
dehydrogenas
np
necrot
pneumonia
ntprobnp
ntermin
prohormon
brain
natriuret
peptid
paco
partial
pressur
carbon
dioxid
arteri
blood
pao
partial
pressur
oxygen
arteri
blood
sd
standard
deviat
wbc
white
blood
cell
present
studi
np
account
hospit
cap
patient
character
higher
frequenc
symptom
higher
psi
class
higher
level
inflammatori
marker
frequent
need
pleural
drainag
suggest
patient
np
experi
sever
clinic
cours
common
pathogen
communityacquir
np
k
pneumonia
follow
aureu
pneumonia
milleri
group
patient
hospit
cap
develop
necrot
chang
influenc
lo
affect
mortal
inhospit
mortal
np
consid
rare
complic
bacteri
lung
infect
howev
inform
regard
proport
np
cap
patient
affect
limit
presenc
parenchym
lung
lesion
requisit
diagnosi
pneumonia
usual
base
new
infiltr
chest
radiograph
howev
chest
radiograph
often
insuffici
detect
pulmonari
parenchym
lesion
pneumonia
chest
ct
scan
improv
diagnosi
cap
institut
emerg
physician
saw
patient
suspect
pneumonia
tend
confirm
pneumonia
transfer
emerg
depart
intern
medicin
depart
therefor
although
ct
scan
usual
necessari
diagnosi
cap
use
major
cap
patient
treat
institut
allow
us
determin
proport
patient
np
therefor
fact
like
reduc
possibl
patient
underw
ct
scan
sever
diseas
present
studi
np
observ
approxim
hospit
cap
patient
similarli
previou
studi
patient
pneumococc
pneumonia
underw
ct
scan
chest
necrot
chang
lung
observ
n
reason
behind
microbi
agent
caus
necrot
chang
lung
parenchyma
one
patient
anoth
remain
elucid
one
possibl
explan
could
differ
gener
condit
immun
statu
patient
present
studi
np
demograph
character
higher
number
male
eversmok
heavi
drinker
commonli
associ
postgastrectomi
statu
chronic
liver
diseas
diabet
consist
previou
review
report
alcohol
diabet
common
comorbid
condit
commonli
accompani
np
durat
symptom
np
group
significantli
longer
nonnp
group
suggest
delay
treatment
could
facilit
necrot
chang
note
previou
review
np
associ
symptom
pneumonia
unfavour
laboratori
data
includ
higher
level
inflammatori
marker
howev
present
studi
clinic
featur
np
associ
inhospit
mortal
suggest
np
sever
pers
increas
risk
mortal
context
mechan
ventil
vasopressor
therapi
clinic
deterior
rate
similar
two
group
interestingli
two
clinic
predict
score
system
show
conflict
result
median
psi
class
higher
np
group
median
score
similar
group
fact
lo
clinic
endpoint
allow
differenti
two
group
multivari
analysi
show
necrot
chang
independ
predict
lo
longer
lo
observ
np
group
could
explain
follow
sever
inflamm
reflect
higher
blood
level
inflammatori
marker
ii
impair
blood
suppli
pulmonari
parenchyma
lead
impedi
antibiot
deliveri
frequent
associ
complic
parapneumon
effus
empyema
requir
pleural
drainag
aetiolog
np
previous
studi
larg
patient
cohort
classic
anaerob
consid
among
import
pathogen
believ
caus
spectrum
aspir
syndrom
includ
aspir
pneumonia
lung
abscess
empyema
pleural
fluid
transthorac
needl
aspir
sourc
specimen
current
avail
obtain
meaning
anaerob
cultur
patient
np
present
studi
anaerob
cultur
blood
pleural
fluid
np
patient
common
microb
k
pneumonia
follow
aureu
pneumonia
milleri
group
find
correspond
studi
pneumonia
aureu
k
pneumonia
common
data
present
n
other
includ
antipseudomon
betalactam
plu
fluoroquinolon
plu
teicoplanin
n
antipseudomon
betalactam
plu
teicoplanin
n
vancomycin
plu
clindamycin
n
teicoplanin
plu
moxifloxacin
n
np
necrot
pneumonia
time
discharg
day
patient
sever
np
requir
surgic
intervent
rate
potenti
drugresist
pathogen
similar
np
nonnp
group
present
studi
sever
limit
present
studi
note
first
limit
retrospect
design
conduct
singl
institut
possibl
select
bia
consid
furthermor
cap
patient
treat
depart
institut
cap
patient
enrol
present
studi
cap
patient
underw
enhanc
ct
scan
although
mani
second
microbiolog
studi
perform
anaerob
lung
tissu
aspir
thu
possibl
anaerob
identifi
caus
agent
consid
moreov
due
retrospect
natur
studi
patient
undergo
test
aetiolog
agent
includ
atyp
pathogen
final
decis
regard
treatment
includ
antibiot
depend
attend
physician
reason
acknowledg
larger
prospect
studi
undertaken
confirm
find
conclus
np
affect
cap
patient
present
studi
associ
sever
clinic
manifest
frequent
need
perform
pleural
drainag
np
differ
microbiolog
nonnp
interestingli
necrot
chang
ct
scan
imag
associ
longer
lo
mortal
patient
cohort
